Opus Genetics (IRD) 10-K2021 FY Annual report

Filed: 24 Mar 22, 5:04pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Bad

New words: AbbVie, accredited, ADME, AGP, API, ATM, Atrophy, BAT, Biden, Black, blurry, bottle, bowel, Brexit, Brimochol, brow, bundled, byTreatment, Canadian, cap, capping, CDMO, CECL, CMC, condensed, CRL, DMF, dry, economy, eighteen, element, encourage, Eotaxin, exit, fabric, Faricimab, fellow, filer, filled, GA, GMP, guanylate, ID, importantly, inconsequential, InflammX, inflationary, inline, JonesTrading, kallikrein, Kingdom, lab, LDP, legacy, Lenz, loan, longevity, macroeconomic, manifesting, Master, Mechanistic, MHRA, mITT, NaN, nightly, nonstatutory, overuse, oxidative, Paper, Paremyd, PDUFA, penny, PKI, POS, PP, predominant, Processa, provisional, RDO, remeasurement, Rescue, Rezolute, Russia, RVO, school, Session, sparse, steady, tester, true, tunability, tunable, twelve, UK, Ukraine, unified, upward, Vabysmo, vega, vertigo, virtual, visibility, vivo, Vuity, VuityTM, Xiflam, younger

Removed: assured, categorized, commitment, concomitant, disclosing, distinguishing, enhance, Hedging, integrated, issuing, kinase, leasing, male, mission, negotiation, notable, penalty, personal, Plaza, Realty, SG, taxing, top, toxicological, transport, Trump, unconstitutional, worse

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IRD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-252715) and Form S-8 (No. 333-254923, 333-249978, 333-217627, 333-189240, and 333-129294) of Ocuphire Pharma, Inc., of our report dated March 24, 2022, relating to the consolidated financial statements of Ocuphire Pharma, Inc., included in this Annual Report (Form 10-K) of Ocuphire Pharma, Inc. for the year ended December 31, 2021.

/s/ Ernst & Young LLP

Detroit, MI

March 24, 2022